Best Available Evidence Links Cell Phone Use to Brain Tumors
Article ID: 570268
Released: 1-Nov-2010 11:30 AM EDT
Source Newsroom: Wolters Kluwer Health: Lippincott Williams and Wilkins
Newswise — The highest-quality research data available suggests that long-term exposure to microwaves from cellular phones may lead to an increased risk of brain tumors, reports a paper in the November/December issue of Journal of Computer Assisted Tomography. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.
Although debate continues, independent studies with long-term follow-up strongly suggest an increased risk of brain tumors related to the use of cellular or cordless phones. "We conclude that the current standard of exposure to microwave during mobile phone use is not safe for long-term exposure and needs to be revised," conclude the study authors, led by R.B. Dubey of Apeejay College of Engineering, Sohna, Gurgaon, India.
Brain Tumor Risk May Double after 10 Years of Cell Phone Use
There is increasing public concern about the potential cancer risks from microwave emissions related to wireless phones—not only cellular phones and base stations (transmission tower antennae), but also home cordless phones. Some studies have reported that long-term wireless phone users have increased rates of brain tumors, including malignant gliomas and benign acoustic neuromas. However, other studies have found no association.
To gain insight into the controversy, Dubey and colleagues performed an in-depth analysis of research on the health risks associated with microwave exposure from wireless phones. To date, only eleven published studies have provided data on the risk of developing brain tumors in long-term cell phone users—ten years or longer.
The largest data source was a series of studies called the Interphone studies, which were largely funded by the wireless communications industry. Based on data from thirteen countries, the Interphone studies concluded that cell phone exposure did not increase the risk of brain tumors. In addition to possible bias associated with industry funding, the studies had some important flaws, including relatively short durations of cell phone use.
However, an independent series of studies led by Swedish cancer specialist Dr. Lennart Hardell reached a different conclusion. Dr. Hardell's studies included more patients who had used a cell phone for ten years or longer and were performed without financial support from the wireless industry. The findings suggested that the more hours of cellular phone use over time, the higher the risk of developing brain tumors. Risk also increased along with the level of power from the wireless device, years since first use, total exposure, and younger age when starting wireless phone use.
Based on an analysis of pooled data from different studies, researchers write, "[L]ong-term cell phone usage can approximately double the risk of developing a glioma or acoustic neuroma in the more exposed brain hemisphere"—that is, on the side where the user typically holds the phone to the ear. That conclusion is consistent even with data on the long-term cell phone users from the Interphone studies.
It's unclear exactly how exposure to microwave radiation from cell phones may increase brain cancer risk. However, studies have shown that the cell signal is absorbed up to two inches in the adult skull. There is special concern about the risks in younger age groups, as cell phone signals penetrate much deeper into the brain in children.
Further studies are needed to definitively determine the risk of brain cancer and other health effects related to long-term use. Meanwhile, Dr. Dubey and coauthors suggest some steps that cell phone users can take to reduce exposure. These include limiting the number and length of calls, restricting children's cell phone use, communicating by text instead of voice, and wearing an "air tube" headset (not a regular wired headset) rather than holding the phone to the ear.
The researchers also urge adoption of newer phones and other technologies to reduce exposure, and call for government action to revise standards for microwave exposure. "The precautionary principle clearly applies in this case, since the problem is possible but not certain and low cost ameliorating actions are easily implemented by industry," Dubey and coauthors conclude. "With over 3 billion people using cell phones and with children among the heaviest users, it is time for governments to mandate precautionary measures to protect their citizens."
About Journal of Computer Assisted Tomography
Journal of Computer Assisted Tomography (JCAT) provides readers with the latest clinical and research developments in computer-based diagnostic imaging. Each bimonthly issue contains as many as 20 original articles on a wide range of pathological conditions. The case reports published in JCAT impart the valuable clinical experience of leading radiologists as unusual, noteworthy, and illuminating cases are examined. The superbly reproduced figures highlight unique imaging findings, the challenging diagnostic dilemmas that they pose, and their ultimate resolution.
Lippincott Williams & Wilkins
Lippincott Williams & Wilkins (LWW) is a leading international publisher for healthcare professionals and students with nearly 300 periodicals and 1,500 books in more than 100 disciplines publishing under the LWW brand, as well as content-based sites and online corporate and customer services.
LWW is part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health and pharmacy. Major brands include traditional publishers of medical and drug reference tools and textbooks, such as Lippincott Williams & Wilkins and Facts & Comparisons®; and electronic information providers, such as Ovid®, UpToDate®, Medi-Span® and ProVation® Medical.
Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance, and healthcare rely on Wolters Kluwer’s leading, information-enabled tools and solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.
Wolters Kluwer has 2009 annual revenues of €3.4 billion ($4.8 billion), employs approximately 19,300 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Alphen aan den Rijn, the Netherlands. Its shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices.